Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis

被引：4
|
作者：
Wahlin, Staffan [1 ,2 ]
Efe, Cumali [3 ]
机构：
[1] Karolinska Inst, Hepatol Div, Dept Upper GI Dis, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Harran Univ, Dept Gastroenterol, Sanliurfa, Turkey
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 03期
关键词：
DISEASES;
D O I：
10.1016/j.jhep.2020.09.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：753 / 755
页数：3
相关论文
共 50 条
  • [41] Dolutegravir for second-line antiretroviral therapy
    Hamers, Raph L.
    LANCET INFECTIOUS DISEASES, 2019, 19 (03): : 218 - 219
  • [42] Second-line therapy in colorectal cancer
    Berlin, J
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 21 - 26
  • [43] OFF-LABEL USE OF MYCOPHENOLATE MOFETIL IN AUTOIMMUNE DISEASES AS A SECOND-LINE THERAPY
    Danza, A.
    Dominguez, V
    Grana, D.
    Vargas, A.
    Berez, A.
    Goni, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 47 - 47
  • [44] Second-line drug therapy for osteoarthritis
    Brandt, KD
    CLINICAL MEDICINE, 2001, 1 (02) : 110 - 112
  • [45] Second-line therapy in bladder cancer
    Bachner, Mark
    De Santis, Maria
    CURRENT OPINION IN UROLOGY, 2009, 19 (05) : 533 - 539
  • [46] Second-Line Therapy for Advanced NSCLC
    Weiss, Jared M.
    Stinchcombe, Thomas E.
    ONCOLOGIST, 2013, 18 (08): : 947 - 953
  • [47] Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (10) : 1260 - 1263
  • [48] TACROLIMUS AS A SECOND LINE THERAPY IN STEROID- TACROLIMUSMYCOPHENOLATE- MOFETIL REFRACTORY AUTOIMMUNE HEPATITIS: EXPERIENCE FROM A TERTIARY CARE CENTER
    Sharma, Mithun
    Kulkarni, Anand V.
    Alla, Manasa
    Sowmya, T. R.
    Rao, Padaki Nagaraja
    Venishetty, Shantan
    Gupta, Rajesh
    Reddy, Nageshwar D.
    HEPATOLOGY, 2023, 78 : S2024 - S2025
  • [49] Alopecia in Patients with Autoimmune Hepatitis Treated by Tacrolimus Therapy
    Yuksekyayla, Osman
    Batibay, Ersin
    Wahlin, Staffan
    Efe, Cumali
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2025, 36 (01):
  • [50] First-line and second-line antiretroviral therapy
    Calmy, A
    Pascual, F
    Ford, N
    LANCET, 2004, 364 (9431): : 329 - 329
12345